Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
2,556,332
-
Total 13F shares
-
22,969,085
-
Share change
-
-1,670,208
-
Total reported value
-
$13,319,975
-
Price per share
-
$0.5800
-
Number of holders
-
47
-
Value change
-
-$980,629
-
Number of buys
-
18
-
Number of sells
-
18
Institutional Holders of Aptose Biosciences Inc. - Common Shares as of Q4 2022
As of 31 Dec 2022 Aptose Biosciences Inc. - Common Shares had 47 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 22,969,085 shares of stock of the company.
Largest 10 holders included DRW Securities, LLC, Nantahala Capital Management, LLC, CARLSON CAPITAL L P, Sigma Planning Corp, Annandale Capital, LLC, MORGAN STANLEY, GOLDMAN SACHS GROUP INC, Voss Capital, LLC, RENAISSANCE TECHNOLOGIES LLC, and BNP PARIBAS ARBITRAGE, SNC.
This table shows 48 institutional shareholders of the security as of 31 Dec 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.